Form 4 for SYRE Spyre Therapeutics, Inc.
Accepted 2026-01-23 00:00:00 ET · period of report 2026-01-21 · accession 0001779990-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-23 | 2026-01-21 | SYRE | HENDERSON MICHAEL THOMAS | Dir | J - Other | $0.00 | +63.2K | 168.6K | +60% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-21 | J | A | 63,227 | $0.00 | 168,606 | D | — | — |